BACH1 (BTB Domain and CNC Homolog 1) encodes a transcriptional repressor that competes with [NRF2](/genes/nfe2l2) for binding to antioxidant response elements (AREs) in the promoters of cytoprotective genes. BACH1 acts as a heme sensor — when intracellular heme levels rise (as occurs during oxidative stress or hemolysis), heme binds to BACH1's cysteine-proline (CP) motifs, triggering its nuclear export and proteasomal degradation. This derepression allows NRF2 to activate target genes including [HMOX1](/genes/hmox1) (heme oxygenase-1), [NQO1](/genes/nqo1), and glutathione synthesis enzymes.
In neurodegenerative diseases, the BACH1-NRF2 axis is a critical determinant of cellular resilience to oxidative stress. BACH1 inhibition represents an emerging therapeutic strategy for enhancing neuroprotective antioxidant responses in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [ALS](/diseases/als).
The protein encoded by BACH1 is [BACH1 Protein](/proteins/bach1-protein). See the protein page for detailed structural and functional information.
Function
Transcriptional Repression
BACH1 functions as a cap'n'collar (CNC) family transcription factor that:
Heterodimerizes with small Maf proteins (MafF, MafG, MafK) to bind Maf recognition elements (MAREs) and AREs
Competes with NRF2 for ARE binding, acting as a constitutive repressor of antioxidant gene expression under basal conditions
Represses HMOX1: The [HMOX1](/genes/hmox1) promoter contains multiple AREs that are occupied by BACH1-Maf heterodimers in the absence of stress
Regulates iron metabolism: Controls ferritin heavy chain (FTH1) and ferroportin (SLC40A1) expression
Heme-Dependent Regulation
BACH1 contains six CP motifs that serve as heme-binding sites:
Heme binding induces conformational change, releasing BACH1 from DNA
Heme-bound BACH1 is exported from the nucleus via CRM1/exportin-1
Cytoplasmic heme-BACH1 is ubiquitinated by [FBXL17](/genes/fbxl17) and degraded by the proteasome
This creates a feed-forward loop: oxidative stress → heme release → BACH1 degradation → NRF2 activation
NRF2-BACH1 Switching Model
Mermaid diagram (expand to render)
Disease Associations
Alzheimer's Disease
BACH1 dysregulation contributes to oxidative damage in [AD](/diseases/alzheimers-disease):
BACH1 protein levels are elevated in AD [hippocampus](/brain-regions/hippocampus), correlating with reduced HMOX1 expression
[Amyloid-beta](/proteins/amyloid-beta) induces oxidative stress but fails to adequately degrade BACH1 in aged [neurons](/entities/neurons)
BACH1 knockout mice show enhanced HMOX1 expression and resistance to amyloid-beta-induced oxidative damage
The BACH1 gene is located on chromosome 21, raising the possibility of gene dosage effects in Down syndrome-associated AD
Parkinson's Disease
In [PD](/diseases/parkinsons-disease), BACH1 opposes neuroprotective NRF2 signaling:
Dopaminergic neurons in the substantia nigra have high oxidative burden due to dopamine metabolism
BACH1 repression of HMOX1 limits the ability of these neurons to cope with iron-mediated oxidative stress
BACH1 inhibition enhances NRF2-dependent protection of dopaminergic neurons in MPTP models
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation impairs the KEAP1-NRF2 pathway, making BACH1 derepression critical
ALS
Motor neurons show vulnerability to oxidative stress, partly mediated by BACH1 repression of antioxidant genes
[SOD1](/entities/sod1) mutant models show altered BACH1-NRF2 balance
BACH1 inhibition is being explored as a strategy to enhance motor neuron resilience
Therapeutic Targeting
BACH1 inhibitors are in development for neurodegenerative diseases:
HMOX1 inducers: Compounds that promote BACH1 degradation and HMOX1 derepression
Direct BACH1 inhibitors: Small molecules blocking BACH1-DNA interaction
Heme mimetics: Synthetic compounds that bind BACH1 CP motifs, triggering its degradation
Expression
BACH1 is ubiquitously expressed with notable levels in:
Brain: Cortical neurons, hippocampal neurons, substantia nigra dopaminergic neurons
Liver: Hepatocytes (major site of heme metabolism)
Spleen: Macrophages involved in erythrocyte clearance
Bone marrow: Erythroid precursors
Immune cells: Monocytes and macrophages (including [microglia](/cell-types/microglia))
See Also
[NFE2L2 (NRF2)](/genes/nfe2l2) — Competing transcription factor at AREs
[KEAP1](/genes/keap1) — NRF2 negative regulator
[HMOX1](/genes/hmox1) — Major BACH1 target gene
[Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress) — Central pathogenic mechanism
[Ogawa et al., Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1 (2001) (2001)](https://doi.org/10.1093/emboj/20.11.2835)
[Reichard et al., Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1 (2007) (2007)](https://doi.org/10.1093/nar/gkm638)
[Ahuja et al., Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease (2021) (2021)](https://doi.org/10.1073/pnas.2111643118)
[Unknown, Igarashi & Watanabe-Matsui, Wearing red for signaling: the heme-bach axis in heme metabolism, oxidative stress response and iron immunology (2014) (2014)](https://doi.org/10.1620/tjem.232.229)
[Sunuwar et al., BACH1 represses ferritinophagy and modulates p62/SQSTM1 levels in cells and in mouse brain (2023) (2023)](https://doi.org/10.1016/j.redox.2023.102762)
[Casares et al., Nrf2 transcription factor: biology and neurological functions (2024) (2024)](https://doi.org/10.1016/j.freeradbiomed.2024.02.002)
Pathway Diagram
The following diagram shows the key molecular relationships involving BACH1 — BTB Domain and CNC Homolog 1 discovered through SciDEX knowledge graph analysis: